A recent study has proven the role of microbiota-derived TLR agonists in promoting hepatic steatosis without affecting fructose-1-phosphate and cytosolic acetyl-CoA, reinforcing the idea that endotoxin engages TLR4 to trigger tumor necrosis factor (TNF) production by liver macrophages (25). The gene discussed is TNF; the disease is fatty liver disease.